Petra Gener

3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial

José Manuel Pérez-García, Javier Cortés, Manuel Ruíz‐Borrego et al. · The Lancet · 2024 · 87 citations

Medicine, Oncology, Breast Oncology +13

Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells

Petra Gener, Guillem Romero Sabat, Diana Rafael et al. · Nanomedicine Nanotechnology Biology and Medicine · 2015 · 85 citations

Medicine, Cell Biology, Oncology +16

Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells

Petra Gener, Sara Montero‐Herradón, Helena Xandri‐Monje et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 64 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin

Fernanda Andrade, José das Neves, Petra Gener et al. · Nanomedicine Nanotechnology Biology and Medicine · 2015 · 55 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticles

Mireia Pesarrodona, Neus Ferrer‐Miralles, Ugutz Unzueta et al. · International Journal of Pharmaceutics · 2014 · 42 citations · Full text

Life Sciences, Cell Biology, Pharmaceutics +14